Alex Rodriguez is being pulled into the Tony Galea-HGH mini-scandal that ensnared Jose Reyes last week. Rodriguez acknowledged a few minutes ago that the feds want to talk to him and that he intends to cooperate with their investigation. While this suggests that A-Rod went up to Canada to have his blood spun Reyes-style last year, Rodriguez is saying that “this is about someone else.”
For his sake it better involve someone else, because if it doesn’t he kept the Yankees totally in the dark about it. The team’s statement:
“The Yankees never authorized Dr. Tony Galea to treat Alex
Rodriguez, nor do we have knowledge of any such treatment.”
Why A-Rod is being questioned about a doctor he suggests never treated him is something of a mystery, and we probably won’t know why, exactly, he’s being questioned until he tells us more.
Not that I imagine this will stop the Daily News and the Post from transforming A-Rod from the redeemed postseason hero figure they’ve taken to recently back into the A-Roid figure they so eagerly created this time last year. Indeed, no matter how tangential or benign A-Rod’s involvement with Dr. Galea was, I have faith that by the time the tabloids hit the streets tomorrow morning, A-Rod will be back in his familiar role as public enemy number one.
Rangers reliever Jake Diekman will have surgery on January 25 to help alleviate ulcerative colitis, an inflammatory bowel disease. As a result, the lefty will miss at least half of the 2017 regular season, Jeff Wilson of the Fort Worth Star-Telegram reports. Diekman was diagnosed with the illness when he was 11 years old. He has brought awareness to the Crohn’s and Colitis Foundation of America with a “Gut It Out” campaign.
Diekman, who turns 30 years old on Saturday, finished the 2016 campaign with a 3.40 ERA and a 59/26 K/BB ratio in 53 innings. He came to the Rangers from the Phillies in the Cole Hamels trade on July 31, 2015.
The Rangers and Diekman avoided arbitration last Friday, agreeing to a $2.55 million salary for the 2017 season.
It’s been on the verge of happening for a few days now, but now it’s official: the Toronto Blue Jays and Jose Bautista have reached a one-year deal with a mutual option. The deal is pending physical. An announcement making the deal official is expected later in week.
The exact financial figures have not been disclosed, but Jon Heyman reports that it will be in excess of the $17.2 million Bautista turned down when he turned down the Jays’ qualifying offer.
Bautista had a tough 2016, hitting .234/.366/.452 with 22 home runs and 69 RBI, and some clubs likely considered a long-term deal for the 36-year-old too risky, this leading to the relative lack of reported interest in Bautista by other clubs. But back-to-back ALCS appearances by the Jays and the success and popularity Bautista has experienced in Toronto make his re-signing there a pretty sensible move for all involved.